Summary
- Current Price
- As of today, GLUE price is $15.67, down -0.25% on
- Current Price All-Time High
- GLUE price is currently -65.61% below its historical high of $45.56 set on
- Market Cap
- GLUE current market cap is $1B, up +253.79% over the past 365 days
- PE Ratio
- GLUE PE ratio is unknown
- Revenue
- GLUE current annual revenue is $123.67M, up +63.54% year-over-year
- Next Earnings
- The next earnings release for GLUE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Monte Rosa Therapeutics, Inc. |
| Ticker | NASDAQ: GLUE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | monterosatx.com |
| Employees | 142 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $15.67 | |
| Price, 1D Change | -0.25% | |
| $1B | ||
| - | ||
| - | ||
| 0.89 | ||
| $124M | ||
| Revenue, 1Y Change | +63.54% | |
| -$0.47 | ||
| EPS, 1Y Change | +52.72% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.47 | ||
| EPS Estimate | N/A | -$1.45 |
| EPS Est. Change | N/A | -212.34% |
| $123.67M | ||
| Revenue Estimate | N/A | $56.75M |
| Revenue Est. Change | N/A | -54.12% |
| Current Price | $15.67 | |
| Price Target | - | $30.50 |
| Price Tgt. Change | - | +94.64% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.21 | -$0.98 | +18.84% | |
| -$0.22 | -$0.47 | -113.30% | |
| -$1.45 | N/A | -212.34% | |
| -$1.72 | N/A | -269.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $59.78M | $75.62M | +26.51% | |
| $136.47M | $123.67M | -9.37% | |
| $56.75M | N/A | -54.12% | |
| $61.50M | N/A | -50.27% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $15.67 | |
| $11.93 | ||
| SMA 200 vs Price | -23.84% | |
| $19.06 | ||
| SMA 50 vs Price | +21.62% | |
| 0.89 | ||
| $1.10 | ||
| 39.07 | ||
| 48.99% | ||
| 96.36% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $123.67M | ||
| -$0.47 | ||
| $115.32M | ||
| 93.24% | ||
| -$54.21M | ||
| -43.83% | ||
| -$38.63M | ||
| -31.23% | ||
| -$45.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.17 | ||
| 6.12 | ||
| 6.12 | ||
| - | ||
| 4 | ||
| 2.59 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 9.66 | ||
| 5.13 | ||
| -18.69 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $233.06M | ||
| $377.10M | ||
| $448.66M | ||
| $393.19M | ||
| $215.60M | ||
| $64.21M | ||
| $39.19M | ||
| $4.40M | ||
| $3.55M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $162.30M | ||
| $169.52M | ||
| $8.36M | ||
| $0.00 | ||
| $8.36M | ||
| $0.00 | ||
| -$1.10M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$22.80M | ||
| -$101.83M | ||
| $30.35M | ||
| $4.70M | ||
| -$27.50M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Guggenheim | → | |
| Piper Sandler | → | |
| Wells Fargo | → | |
| Guggenheim | → | |
| Wells Fargo | → | |
| Wells Fargo | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| LifeSci Capital |
Analyst sentiment
Institutional ownership
Screeners with GLUE
FAQ
What is the ticker symbol for Monte Rosa Therapeutics, Inc.?
The ticker symbol for Monte Rosa Therapeutics, Inc. is NASDAQ:GLUE
Does Monte Rosa Therapeutics, Inc. pay dividends?
No, Monte Rosa Therapeutics, Inc. does not pay dividends
What sector is Monte Rosa Therapeutics, Inc. in?
Monte Rosa Therapeutics, Inc. is in the Healthcare sector
What industry is Monte Rosa Therapeutics, Inc. in?
Monte Rosa Therapeutics, Inc. is in the Biotechnology industry
What country is Monte Rosa Therapeutics, Inc. based in?
Monte Rosa Therapeutics, Inc. is headquartered in United States
When did Monte Rosa Therapeutics, Inc. go public?
Monte Rosa Therapeutics, Inc. initial public offering (IPO) was on June 24, 2021
Is Monte Rosa Therapeutics, Inc. in the S&P 500?
No, Monte Rosa Therapeutics, Inc. is not included in the S&P 500 index
Is Monte Rosa Therapeutics, Inc. in the NASDAQ 100?
No, Monte Rosa Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Monte Rosa Therapeutics, Inc. in the Dow Jones?
No, Monte Rosa Therapeutics, Inc. is not included in the Dow Jones index
When was Monte Rosa Therapeutics, Inc. last earnings report?
Monte Rosa Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Monte Rosa Therapeutics, Inc. report earnings?
The next expected earnings date for Monte Rosa Therapeutics, Inc. is May 7, 2026
Data Sources & References
- GLUE Official Website www.monterosatx.com
- GLUE Profile on Yahoo Finance finance.yahoo.com/quote/GLUE
- GLUE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/glue